Yuxin Chen

1.2k total citations
31 papers, 413 citations indexed

About

Yuxin Chen is a scholar working on Molecular Biology, Sensory Systems and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yuxin Chen has authored 31 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Sensory Systems and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yuxin Chen's work include Hearing, Cochlea, Tinnitus, Genetics (10 papers), RNA regulation and disease (10 papers) and CRISPR and Genetic Engineering (8 papers). Yuxin Chen is often cited by papers focused on Hearing, Cochlea, Tinnitus, Genetics (10 papers), RNA regulation and disease (10 papers) and CRISPR and Genetic Engineering (8 papers). Yuxin Chen collaborates with scholars based in China, United States and Canada. Yuxin Chen's co-authors include Yilai Shu, Geng‐Lin Li, Daqi Wang, Huawei Li, Shengyi Wang, Honghai Tang, Jun Lv, Chong Cui, Fang Wang and Xingxu Huang and has published in prestigious journals such as Cell, Nature Communications and Neuron.

In The Last Decade

Yuxin Chen

26 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuxin Chen China 13 277 137 68 57 48 31 413
Elise Pepermans France 9 334 1.2× 287 2.1× 60 0.9× 48 0.8× 43 0.9× 12 486
Pankhuri Vyas United States 10 164 0.6× 92 0.7× 34 0.5× 62 1.1× 29 0.6× 15 311
Qing‐qing Jiang China 9 193 0.7× 85 0.6× 19 0.3× 42 0.7× 18 0.4× 24 387
Victor H. Hernández Mexico 6 295 1.1× 136 1.0× 106 1.6× 29 0.5× 24 0.5× 14 429
Maria Sol Collado United States 13 247 0.9× 230 1.7× 115 1.7× 89 1.6× 14 0.3× 22 564
Carolyn Hope New Zealand 7 218 0.8× 92 0.7× 87 1.3× 44 0.8× 37 0.8× 7 343
Janet L. Cyr United States 7 226 0.8× 147 1.1× 23 0.3× 33 0.6× 16 0.3× 10 398
Amrit Singh‐Estivalet France 9 218 0.8× 107 0.8× 55 0.8× 17 0.3× 62 1.3× 11 362
Ana E. Vázquez United States 14 570 2.1× 260 1.9× 189 2.8× 71 1.2× 19 0.4× 20 861
Rajanikanth J Maganti United States 6 278 1.0× 378 2.8× 19 0.3× 68 1.2× 24 0.5× 9 583

Countries citing papers authored by Yuxin Chen

Since Specialization
Citations

This map shows the geographic impact of Yuxin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxin Chen more than expected).

Fields of papers citing papers by Yuxin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxin Chen. The network helps show where Yuxin Chen may publish in the future.

Co-authorship network of co-authors of Yuxin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxin Chen. A scholar is included among the top collaborators of Yuxin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxin Chen. Yuxin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hui, Jingjing Zhao, Guotao Tang, et al.. (2025). Comparative analysis of RNA versus protein splicing in dual AAV-mediated gene therapy in a mouse model of DFNB9 deafness. Molecular Therapy. 34(1). 203–215.
2.
Liu, Huanhuan, Yuxin Chen, Fuping Zhang, et al.. (2025). rTMS ameliorates CUMS-induced anxiety-depression-like behaviour and cognitive dysfunction in rats by modulating the COX-2/PGE2 signalling pathway. Journal of Psychiatric Research. 186. 116–128. 3 indexed citations
4.
Chen, Yuxin, et al.. (2025). Mapping RNA–Protein Interactions via Proximity Labeling‐Based Approaches. Chemistry - An Asian Journal. 20(12). e202500118–e202500118.
5.
Tian, Tian, Yuxin Chen, Zhiqiang Qiu, et al.. (2025). Identification of a key nucleotide influencing Cas12a crRNA activity for universal photo-controlled CRISPR diagnostics. Nature Communications. 16(1). 6694–6694. 5 indexed citations
6.
Wang, Hui, Honghai Tang, Jingjing Zhao, et al.. (2024). Hair cell-specific Myo15 promoter-mediated gene therapy rescues hearing in DFNB9 mouse model. Molecular Therapy — Nucleic Acids. 35(1). 102135–102135. 15 indexed citations
7.
Zhu, Jun‐Jie, et al.. (2024). Analyzing the Spatiotemporal Dynamics of Drought in Shaanxi Province. Atmosphere. 15(11). 1264–1264.
8.
Chen, Yuxin, et al.. (2024). Gene therapy for deafness: we can do more. Nature Reviews Genetics. 26(4). 225–226. 1 indexed citations
9.
Jiang, Luoying, Zijing Wang, Yi Zhou, et al.. (2024). Hearing restoration by gene replacement therapy for a multisite-expressed gene in a mouse model of human DFNB111 deafness. The American Journal of Human Genetics. 111(10). 2253–2264. 4 indexed citations
10.
Wang, Zijing, Honghai Tang, Hui Wang, et al.. (2024). Engineering of the AAV-Compatible Hair Cell-Specific Small-Size Myo15 Promoter for Gene Therapy in the Inner Ear. Research. 7. 341–341. 6 indexed citations
11.
Zhang, Xiang, Yuxin Chen, Fang Wang, et al.. (2023). Asymmetric pendrin homodimer reveals its molecular mechanism as anion exchanger. Nature Communications. 14(1). 3012–3012. 18 indexed citations
12.
Zhang, Longlong, Jinghan Wang, Biyun Zhu, et al.. (2023). Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates. Molecular Therapy — Methods & Clinical Development. 31. 101154–101154. 21 indexed citations
13.
14.
Cui, Chong, Luping Zhang, Fuping Qian, et al.. (2022). A humanized murine model, demonstrating dominant progressive hearing loss caused by a novel KCNQ4 mutation (p. G228D ) from a large Chinese family. Clinical Genetics. 102(2). 149–154. 6 indexed citations
15.
Cui, Chong, Daqi Wang, Fang Wang, et al.. (2022). Precise detection of CRISPR-Cas9 editing in hair cells in the treatment of autosomal dominant hearing loss. Molecular Therapy — Nucleic Acids. 29. 400–412. 36 indexed citations
16.
Chen, Yuxin, et al.. (2022). Remote-Sensing Drought Monitoring in Sichuan Province from 2001 to 2020 Based on MODIS Data. Atmosphere. 13(12). 1970–1970. 5 indexed citations
17.
Guo, Li, Chong Cui, Fang Wang, et al.. (2022). Preventing autosomal-dominant hearing loss in Bth mice with CRISPR/CasRx-based RNA editing. Signal Transduction and Targeted Therapy. 7(1). 79–79. 48 indexed citations
18.
Zhou, Juan, et al.. (2022). Ecological Sensitivity Assessment of the Southeastern Qinghai-Tibet Plateau using GIS and AHP—A Case Study of the Nyingchi Region. Journal of Resources and Ecology. 14(1). 4 indexed citations
19.
Liu, Yajing, Shaoshuai Mao, Shisheng Huang, et al.. (2020). REPAIR x, a specific yet highly efficient programmable A > I RNA base editor. The EMBO Journal. 39(22). e104748–e104748. 34 indexed citations
20.
Li, Yongqin, Yuxin Chen, Shaoshuai Mao, et al.. (2020). In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice. Nature Communications. 11(1). 2781–2781. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026